Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
2027, the University of Tokyo will launch UTokyo College of Design (UTokyo Design) — a bold new educational program set to redefine how design shapes the future. This is an innovative integrated
-
above. Mathematical Science and Quantum Computation RIKEN Interdisciplinary Theoretical and Mathematical Sciences Program (Program Director: Tetsuo Hatsuda) (Scheduled to change to “Quantum Mathematical
-
Science Initiative is a graduate program that focuses on "fusion of disciplines" to create a new academic discipline by fusing multiple fields of expertise. There are two divisions according to the spread
-
close collaborations among researchers from different disciplines in theoretical, mathematical and computational sciences. On April 1, 2025, iTHEMS transitioned from a program to a center. The ultimate
-
center under the World Premier International Research Center (WPI) program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT). At NanoLSI, the world's most advanced bio-SPM
-
researchers from different disciplines in theoretical, mathematical and computational sciences. On April 1, 2025, iTHEMS transitioned from a program to a center. The ultimate goal of iTHEMS is to unravel
-
. iTHEMS aims to nurture and support young scientists eager to cross disciplinary boundaries. On April 1, 2025, iTHEMS was reorganized from a Program into a Center. iTHEMS aims to elucidate the universe
-
change. About the Role This position is part of a 5-year PhD degree program offered through Hiroshima University (HU), specifically within the Graduate School of Advanced Science and Engineering or
-
. OIST is a dynamic new graduate university of science and technology in Okinawa Prefecture, Japan which offers a 5-year PhD program and brings together outstanding researchers from across the country and
-
Tenure-Track Assistant Professor at the Graduate School of Pharmaceutical Studies, Tohoku University
research approaches, including but not limited to those that leverage emerging technologies—such as AI-based analysis, computational science, and iPS cell-based drug discovery models—to identify novel drug